A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase Inhibitor
Julia Kinsolving, Lukas Grätz, Jan Hendrik Voss, Bente Löw, Emily Shorter, Baptiste Jude, Johanna T Lanner, Stefan Löber, Peter Gmeiner, Gunnar Schulte · 2024
Read A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase Inhibitor by Julia Kinsolving, Lukas Grätz, Jan Hendrik Voss, Bente Löw, Emily Shorter, Baptiste Jude, Johanna T Lanner, Stefan Löber, Peter Gmeiner, Gunnar Schulte (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11684006.txt.
Description
Julia Kinsolving and co-authors issue a caution in 2024 about a supposed cancer drug lead. A computer screen had flagged a compound as blocking a receptor that drives gut cancers, based on a glow-based test. Such tests can mislead when the compound blocks the glow itself rather than the target.
On retesting, the compound proved to be a strong blocker of the glow enzyme at the same dose reported for the cancer effect. Two glow-free methods, a receptor sensor and a gene readout, showed no effect on the receptor or its target gene. The team underlines why screening hits need counter-screens that check the detection tool itself.
Catalog record
| CREATOR | Julia Kinsolving, Lukas Grätz, Jan Hendrik Voss, Bente Löw, Emily Shorter, Baptiste Jude, Johanna T Lanner, Stefan Löber, Peter Gmeiner, Gunnar Schulte |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |